Clinical Trials Sponsored by Under Armour

Total 209 results

Johns Hopkins University
Under Armour, Inc.

Terminated

Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation

Breast Cancer | Fatigue | Cognitive Dysfunction

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Under Armour

Completed

Cancer, Obesity/Overweight and Insomnia Study (COIN)

Breast Cancer | Insomnia | Overweight and Obesity

United States
Marmur Medical

Completed

Hyaluronic Acid Filler for Dorsal Finger Volume Loss

Personal Satisfaction

United States
Beliz Önder

Completed

Peri-implant Phenotype, Calprotectin and Mmp-8 Levels in Cases Diagnosed With Peri-implant Disease

Peri-Implantitis | Peri-implant Mucositis

Turkey
Yarmouk University

Completed

The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak

Covid19

Jordan
Dr. Marcus Unger

Completed

Gut-derived Neuropeptides in Cerebrospinal Fluid of Patients With Parkinson's Disease and Healthy Controls

Parkinson's Disease

Germany
Yarmouk University

Completed

Spleen Preserving Surgery for Splenic Hydatidosis: A Cohort Study on Short and Long-Term Outcomes

Minimally Invasive Surgery | Hydatid Disease | Spleen-Preserving Surgery | Echinococcus Granulosus Infection

Jordan
Yarmouk University

Completed

Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan

Bacterial Infections | Surgical Site Infection | Antibiotic Resistant Infection

Jordan
Arthur F Gelb MD

Completed

Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange

COPD

United States
Royal College of Surgeons, Ireland
Private Philanthropic Funder

Completed

Connect-5 Needs Assessment Survey to Identify Healthy Lifestyle Requirements of a Rural Irish Community (CONNECT-5)

Healthy Lifestyle

Ireland
Ascopharm Groupe Novasco
AscoPharm is conducting the study under the responsibility of SEPTODONT

Completed

Efficacy and the Safety Study of RD94 in Patients With Endodontic Care (RD94)

Tooth Injury

France
Gelb, Arthur F., M.D.

Recruiting

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Emphysema | COPD, Emphysema, Asthma COPD Overlap

United States
Gelb, Arthur F., M.D.

Recruiting

Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Asthma

United States
Harbour BioMed US, Inc.

Completed

A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

Australia, China, Hong Kong
Harbour BioMed US, Inc.

Not yet recruiting

A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of HBM1020 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor
Dental Innovation Foundation Under Royal Patronage
Mahidol University; Ministry of Health, Thailand; Srinakharinwirot University

Completed

Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients

Dry Mouth | Radiation-Induced Xerostomia | Cancer of Head Neck

Thailand
Gelb, Arthur F., M.D.

Recruiting

Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

Asthma

United States
Gelb, Arthur F., M.D.

Completed

Zileuton and Exhaled Nitric Oxide in Asthmatics

Asthma

United States
Arbor Pharmaceuticals, Inc.

Active, not recruiting

Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry (VIGILANT)

CNS Tumor

United States
Arbor Pharmaceuticals, Inc.

Completed

An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension

Hypertension

United States, Brazil, Turkey, Poland, Mexico, Colombia, Italy, Argentina, Bulgaria, Hungary, South Africa, Ukraine
Arbor Life Labs

Completed

A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss (REBOOT-WOMEN)

Androgenetic Alopecia | Androgenic Alopecia | Hair Loss/Baldness | Hair Thinning | Telogen Effluvium | Thinning Hair

United States
Arbor Pharmaceuticals, Inc.

Completed

Relative Bioavailability of AR10 Compared to Reference Product

Healthy
Arbor Pharmaceuticals, Inc.

Completed

Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media

Pain | Otitis Media

United States
Arbor Pharmaceuticals, Inc.

Completed

Phase 3 Study to Compare the Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01006)

Acute Otitis Media

United States
Arbor Pharmaceuticals, Inc.

Terminated

Phase I Rising-dose Study to Assess Tolerability, Safety, Pharmacokinetics, Pharmacodynamics of AR09

Anesthesia

United States
Arbor Life Labs

Completed

A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss (REBOOT-MEN)

Androgenetic Alopecia | Androgenic Alopecia | Hair Loss/Baldness | Hair Thinning | Telogen Effluvium | Thinning Hair

United States
Arbor Pharmaceuticals, Inc.

Completed

AR08 for Treatment of ADHD in Children

ADHD

United States
Arbor Pharmaceuticals, Inc.

Completed

A Comparison of Various Combinations of BiDil Capsules and BiDil Tablets in Healthy Human Volunteers

Healthy

United States
Dental Innovation Foundation Under Royal Patronage
Mahidol University; Ministry of Health, Thailand; Srinakharinwirot University

Completed

The Safety and Efficacy Test of Nutri-PEITC Jelly in Head and Neck Cancer Patients

Quality of Life | Head and Neck Neoplasms | Nutrition Related Cancer

Thailand
Dental Innovation Foundation Under Royal Patronage
Mahidol University; Srinakharinwirot University; Maha Vajiralongkorn Thanyaburi...

Completed

A Pharmacokinetic Study of Nutri-PEITC Jelly in Head and Neck Cancer Survivors

Head and Neck Cancer
SUNDER LAL NEGI

Completed

Myocardial Protection and Clinical Outcome in Patients Undergoing Tetralogy of Fallot Repair : A Randomized Study of Two Different Cardioplegia Technique (TOF)

Myocardial Protection in TOF Repair
Arbor Pharmaceuticals, Inc.

Completed

Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

Attention Deficit Hyperactivity Disorder

United States
Arbor Pharmaceuticals, Inc.

Completed

Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Arbor Pharmaceuticals, Inc.

Terminated

Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)

Acute Otitis Media

United States
Arbor Pharmaceuticals, Inc.

Completed

Pharmacodynamic and Pharmacokinetic Study of BiDil Extended-release Capsules and Commercial BiDil Tablets

Heart Failure

United States
Arbor Pharmaceuticals, Inc.

Terminated

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Vasomotor Symptoms (VMS)

United States
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia Gravis

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combine With Toripalimab in Patients With Advanced HCC and Other Solid Tumors

Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

Healthy Chinese Volunteers

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

Evaluate the Efficacy and Safety of HBM9161(HL161)Subcutaneous Injection in Patients With Generalized MG Patients (MG)

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye

Dry Eye

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP

Primary Immune Thrombocytopenic Purpura

China
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study of HBM9161 in NMOSD Patients

NMO Spectrum Disorder

China
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Trial of HBM9378 in Healthy Chinese Subjects

Asthma

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study

Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Thyroid Ophthalmopathy

China
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Solid Tumor
Harbour BioMed (Guangzhou) Co. Ltd.

Not yet recruiting

Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab

Solid Tumors
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients

Myasthenia Gravis

China
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

Dry Eye

China

Clinical Trials Sponsored by Under Armour

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations